Updated findings on a new approach to ER-positive/HER2-negative breast cancer

Focused chemists in lab coats and safety goggles making experiments.

A UCLA Jonsson Comprehensive Cancer Center researcher and collaborators in a multicenter study will present updated results and plans for further research on a new approach to treating advanced ER-positive/HER2-negative breast cancer.

Uber launches driverless rides with AV company Motional

Previous article

Watch: Big Medicaid changes in California leave millions of patients behind

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations